Search

Zhong Y Li

from New York, NY
Get Report
Also known as:
Zhong You Li
Related to:
Xiu Y LinYing Li, 51Chun Y ChenShao X Li, 51Li Shen, 55Yan Chen Chun, 51Wu Lihong
Connected to:
Ai Q Li, 64Ai H Li, 81Aida Li, 67Aijun Li, 65Aiwen Q Li, 56Aiyan Li, 61Alan Li, 80Alice Li, 46Alida Li, 59Alisha Li, 31

Zhong Li Phones & Addresses

  • New York, NY

Resumes

Resumes

Zhong Li Photo 1

Zhong Li New York, NY

View page
Work:
School of Management
Binghamton, NY
Aug 2011 to May 2012
Treasurer of Graduate Management Association
Broome County Department of Social Services
Binghamton, NY
Feb 2012 to Apr 2012
Quality Reviewer for IRS Volunteer Income Tax Assistance Program
International Business

Aug 2010 to Dec 2010
Teaching Assistant for Introduction
Glenn Bartle Library
Binghamton, NY
Sep 2007 to Dec 2010
Circulation Assistant, Reserves Assistant
United Reliance Inc
New York, NY
Jul 2010 to Aug 2010
Accounting Assistant
Education:
Binghamton University, State University of New York
Binghamton, NY
May 2012
Master of Science in Accounting
Binghamton University, State University of New York
Binghamton, NY
2007 to 2011
Bachelor of Science in Accounting

Business Records

Name / Title
Company / Classification
Phones & Addresses
Zhong Li
Managing
Ridgewood Property LLC
Real Estate Agent/Manager
24015 68 Ave, Flushing, NY 11362
Zhong Li
Managing
Cheng Du LLC
Zhong Ya Li
Secretary, Treasurer
Gfr Pharmaceuticals Inc
Zhong Mei Li
JADE BEAUTY DAY SPA INC
143 E 34 St Ground, New York, NY 10016
Zhong Jian Li
LEE'S FARM INC
41-51 Kenmare St, New York, NY 10012
Zhong Yi Li
JILONG HANG TRADING INC
Whol Nondurable Goods
29 Ave W 11F, Brooklyn, NY 11223
29 Ave W, Brooklyn, NY 11223
Zhong Gin Li
DADA INTERNATIONAL (U.S.A.), INC
160 W 66 St SUITE 23F, New York, NY 10023
160 W 60 St 23F, New York, NY 10023
Zhong Kai Li
JENNIFER BEAUTY SPA, INC
Physical Fitness Facility
83-19 Broadway, Elmhurst, NY 11373
8319 Broadway, Flushing, NY 11373
83-19 Broadway 2, Elmhurst, NY 11373

Publications

Isbn (Books And Publications)

Integration of Fuzzy Logic And Chaos Theory

View page
Author

Zhong Li

ISBN #

3540268995

Fuzzy Chaotic Systems : Modeling, Control, and Applications

View page
Author

Zhong Li

ISBN #

3540332200

Us Patents

3,6-Disubstituted Penam Sulfone Derivatives

View page
US Patent:
6395726, May 28, 2002
Filed:
Jan 24, 2000
Appl. No.:
09/489623
Inventors:
Panayota Bitha - Nanuet NY
Zhong Li - Congers NY
Gerardo D. Francisco - Orangeburg NY
Assignee:
American Cyanamid Company - Madison NJ
International Classification:
A01N 4300
US Classification:
51421005, 540310
Abstract:
Compounds are provided having the following formulae I and II: wherein n is 0 or 1 and when n=1, R is a 5 or 6 membered heterocyclic ring, hydroxy, halogen, oxo, carbamoyl, alkoxy, or disubstituted amino, when n=0, R is an ester, cyano or amide group; X is CH or NH; R is cyano, methoxy, or acetamido; R is hydrogen, alkyl, a negative charge, a cation selected from the group consisting of sodium, potassium and tetraalkylammonium and acyloxyalkyl, or alkoxycarbonyloxyalkyl; and R is hydrogen, acyl, trisubstituted silyl carbamoyl or an amino acid residue; or pharmaceutically acceptable salts thereof.

Process Improvement In The Preparation Of (4R, 5S, 6S)-3-[[(2R,3R)-2-[[[(S)-2-Amino-3-Methyl-1-Oxobutyl]Amino]Methyl]Tetrahydro-3-Furanyl]Thio]-6-[(R)-1-Hydroxyethyl]-4-Methyl-7-Oxo-1-Azabicyclo[3.2.0]Hept-2-Ene-2-Carboxylic Acid

View page
US Patent:
6649756, Nov 18, 2003
Filed:
Jul 9, 2001
Appl. No.:
09/901335
Inventors:
Tarek Mansour - New City NY
Zhong Li - Congers NY
Assignee:
Wyeth, Five Giralda Farms - Madison NJ
International Classification:
C07D47720
US Classification:
540350
Abstract:
The invention is a process improvement for producing the carbapenem antibacterial agent (4R, 5S, 6S)-3-[[2R,3R)-2-[[[(S)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3. 2. 0]hept-2-ene-2-carboxylic acid by hydrogenation of 4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-{[2R,3R)-2-({[(2S)-3-methyl-2-({[4-nitrobenzyl)oxy]carbonyl}amino)butanoyl]amino}methyl)-tetrahydrofuran-3-yl]thio}-7-oxo-1-azabicyclo[3. 2. 0]hept-2-ene-2-carboxylate in a biphasic solvent mixture comprising a water portion and an organic solvent portion, not containing an acid acceptor. The water portion is separated from the organic solvent portion and (4R,5S,6S)-3-[[(2R,3R)-2-[[[(S)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[R-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3. 2. 0]hept-2-ene-2-carboxylic acid is isolated from the separated water portion by lyophilization or reverse osmosis.

Nucleoside Peptide Antibiotics Of Aa-896

View page
US Patent:
6727232, Apr 27, 2004
Filed:
Apr 25, 2002
Appl. No.:
10/131939
Inventors:
Zhong Li - Congers NY
Gerardo DelaCruz Francisco - Orangeburg NY
Leonard Alexander McDonald - Mountainside NJ
Assignee:
Wyeth Holdings Corporation - Madison NJ
International Classification:
A01N 4304
US Classification:
514 50, 514 43, 514 49, 536 221, 536 281, 536 284, 536 2853, 536 553
Abstract:
This invention relates to antibiotic compounds AA896 of the formula wherein: R is H, aryl, alkyl (C -C ), âCH -aryl, âC(O)alkyl(C -C ), âC(O)NHalkyl(C -C ), or âC(O)NHaryl; R is H, alkyl (C -C ), âCH aryl, alkyl (C -C ) or âC(O)alkyl(C -C ); R is âOH; R and R may optionally be taken together to form a moiety R is alkyl (C -C ), or aryl; or a pharmaceutically acceptable salt thereof.

Beta-Sulfonamide Hydroxamic Acid Inhibitors Of Tace/Matrix Metalloproteinase

View page
US Patent:
7595327, Sep 29, 2009
Filed:
Mar 16, 2006
Appl. No.:
11/377886
Inventors:
Jeremy I. Levin - New City NY, US
Zhong Li - Congers NY, US
George Diamantidis - Randolph NJ, US
Frank E. Lovering - Acton MA, US
Weiheng Wang - Bedford MA, US
Jeffrey S. Condon - Cambridge MA, US
Jerauld S. Skotnicki - Westfield NJ, US
Kaapjoo Park - Congers NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/44
C07D 453/02
US Classification:
514306, 514451, 514461, 546134, 546135, 549356, 549362, 549429
Abstract:
This invention provides compounds of Formula I, having the structure:.

Methods For Global Pattern Discovery Of Genetic Association In Mapping Genetic Traits

View page
US Patent:
20040219567, Nov 4, 2004
Filed:
Nov 5, 2003
Appl. No.:
10/703063
Inventors:
Andrea Califano - New York NY, US
Aristidis Floratos - Astoria NY, US
Zhong Li - Rutherford NJ, US
David Wang - Kildeere IL, US
International Classification:
C12Q001/68
G06F019/00
G01N033/48
G01N033/50
US Classification:
435/006000, 702/020000
Abstract:
A pattern discovery-based method for identifying genetic associations in mapping complex traits. In one embodiment, this invention describes the applicable study designs, the pattern discovery algorithm on phenotypic/genotypic data, and methods to evaluate statistical significance of identified patterns. Patterns identified through the proposed methods act as signatures or profiles that can be used to locate genes or genomic regions responsible for the traits of interests in the genome. This invention has been successfully applied to two independent datasets collected from actual genetic studies and has produced significant results.

Dihydropyrazolo[1,5-A]Pyrimidine And Dihydroimidazo[1,5-A]Pyrimidine Derivatives And Methods Of Use Thereof

View page
US Patent:
20070219183, Sep 20, 2007
Filed:
Mar 15, 2007
Appl. No.:
11/724489
Inventors:
Jeremy Ian Levin - New City NY, US
Zhong Li - Congers NY, US
Dennis Powell - Cortlandt Manor NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/554
A61K 31/553
A61K 31/551
A61K 31/541
A61K 31/5377
A61K 31/519
C07D 487/04
US Classification:
51421115, 5142591, 5142593, 5142342, 51425216, 5142278, 514218, 51421706, 544281, 544114, 544 60, 540575, 540544, 540600
Abstract:
The present invention relates to dihydropyrazolo[1,5-a]pyrimidine and dihydroimidazo[1,5-a]pyrimidine derivatives, compositions comprising an effective amount of a dihydropyrazolo[1,5-a]pyrimidine or a dihydroimidazo[1,5-a]pyrimidine derivative and methods for treating or preventing cancer, comprising administering to a subject in need thereof an effective amount of a dihydropyrazolo[1,5-a]pyrimidine or a dihydroimidazo[1,5-a]pyrimidine derivative.

Multi-Dimensional Data Merge

View page
US Patent:
20090254588, Oct 8, 2009
Filed:
Jun 19, 2007
Appl. No.:
11/764958
Inventors:
Zhong Li - Livingston NJ, US
International Classification:
G06F 17/30
US Classification:
707201, 707E17007
Abstract:
The invention is directed to a system and method for merging at least two datasets each having at least two keys and each having a plurality of data elements. The system determines a quantity of shared data elements in each dataset for each key as well as a quantity of unique data elements in each dataset for each key. The system then generates a graphical output representing the quantity of shared and unique data elements in each dataset for each key. The system receives a selection input selecting one of a plurality of merge strategies. Each merge strategy is based on the quantity shared or unique data elements in each dataset for each key. The system then generates a merged dataset containing data elements from the at least two datasets based on the at least two keys and the selected merge strategy.

Indole-Substituted 3-Cyanopyridines As Kinase Inhibitors

View page
US Patent:
20110028455, Feb 3, 2011
Filed:
Dec 12, 2008
Appl. No.:
12/746855
Inventors:
Diane Harris Boschelli - New City NY, US
Yanong Daniel Wang - Warren NJ, US
Amarnauth Shastrie Prashad - New City NY, US
Zhong Li - Congers NY, US
Chuansheng Niu - Cheshire CT, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 31/551
C07D 401/12
A61K 31/4439
A61P 11/06
A61P 19/02
A61P 17/06
A61P 1/00
C07D 405/14
A61K 31/496
C07D 401/14
A61K 31/4545
C07D 413/14
A61K 31/5355
US Classification:
514218, 5462774, 514339, 544364, 51425309, 544373, 51425409, 546194, 514318, 544129, 5142352, 540575
Abstract:
Disclosed are compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X is —O—, —N(R)—, —S—, —S(O)— or —S(O)—; Ris a Calkyl group or —CF; and R, R, Rand p are as defined herein; wherein the compounds are useful as kinase inhibitors. Also disclosed are pharmaceutical compositions containing, and intermediate compounds and methods for making the compounds of formula (I) and their pharmaceutically acceptable salts; and methods of using the foregoing to treat inflammatory and autoimmune diseases such as asthma, colitis, multiple sclerosis, psoriasis, arthritis, rheumatoid arthritis, inflammatory bowel disease, and joint inflammation.
Control profile
Zhong Y Li from New York, NY Get Report